Cleveland Clinic spin-out reports on heart tissue repair

Juventas Therapeutics, a 2007 spin-out of the Cleveland Clinic in the US, has reported the completion of a Phase 1 study of its regenerative medicine product for heart failure. No adverse events related to the treatment were reported.